Midjourney, the company best known for turning text prompts into striking images, stepped away from its usual playground on Tuesday to announce a venture into medical hardware. The firm introduced the "Midjourney Scanner," a full‑body ultrasonic system that can produce a three‑dimensional map of a person’s anatomy in roughly 60 seconds. The announcement, posted on the company’s blog, stressed that the new product marks the debut of Midjourney Medical, the division tasked with turning consumer‑grade imaging into a health‑care disruptor.
Unlike traditional MRI machines that require a quiet, shielded room and a scan that can stretch up to an hour and a half, the Midjourney Scanner relies on an array of half a million tiny ultrasonic emitters. As a person steps onto a platform, a water‑filled tunnel submerges them at a steady pace of two inches per second. The ring of emitters, each comparable in size to a grain of sand, shoots ultrasonic pulses that bounce off organs and tissues. Sensors capture the returning echoes, and algorithms stitch the data into a high‑resolution, millimeter‑scale 3‑D model. Midjourney likens the experience to being surrounded by a swarm of dolphins using echolocation.
The technology is not built from scratch. Midjourney secured an exclusive licensing deal with Butterfly Network, a maker of handheld ultrasound devices, in November 2025. The partnership grants Midjourney access to Butterfly’s ultrasound‑on‑chip platform, allowing the company to pack sophisticated imaging capabilities into a compact, water‑based scanner. Ahmad Abbas, who heads consumer hardware projects at Midjourney and previously worked on Apple’s Vision Pro, leads the development effort.
Midjourney’s rollout plan emphasizes consumer convenience as much as clinical accuracy. The first installations will be housed in “Spas”—modern wellness centers where customers can step onto the scanner and walk out with a full‑body image in less than a minute. The debut spa is slated for San Francisco sometime next year, with additional locations expected as the company refines the hardware and software. Over the next 12 months, Midjourney will conduct research trials, improve its algorithms, and design a second‑generation version of the scanner.
Regulatory clearance remains a critical hurdle. The firm intends to submit the scanner for FDA approval shortly after the research phase, aiming to have diagnostic use authorized before the end of the year. Midjourney envisions a third‑generation device by 2028 that will employ custom silicon to boost image quality and bring the system closer to the performance of conventional MRI scanners.
Long‑term, Midjourney sets an ambitious target: 50,000 scanners in operation worldwide by 2031. The company argues that widespread, low‑cost imaging could prevent 30 percent of deaths and halve health‑care expenditures by catching conditions early. While critics may question whether a spa‑based scanner can replace hospital‑grade diagnostics, Midjourney’s blend of AI‑driven image processing and rapid ultrasonic capture positions it as a potential game‑changer in preventive medicine.
Este artículo fue escrito con la asistencia de IA.
News Factory APP - noticias agénticas para impulsar tu SEO y AEO.